Havey Adam
SEC CIK 1514588 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| EBS | Emergent BioSolutions Inc. | EVP, Business Ops | 174.4K | — | — | 11 | 2022-02-22 | 2023-06-09 |
Most active insiders at EBS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | DeGolyer Donald W | Dir | — | $317.6K |
| 2 | Glessner Coleen | EVP, Quality, Ethics, CPL | — | $306.1K |
| 3 | Richard Ronald | Dir | — | $263.1K |
| 4 | Dayal Sujata Tyagi | Dir | — | $201.1K |
| 5 | Zoon Kathryn C | Dir | — | $144.5K |
| 6 | Katkin Keith | Dir | — | $128.2K |
| 7 | Williams Paul Anthony | SVP, Products Business | — | $59.0K |
| 8 | Lowry Simon C | SVP, CMO, R, D | — | — |
| 9 | Perl Jessica | SVP, GC, Corp Sec | — | — |
| 10 | Hartzel William | SVP, Bioservices | — | — |
Havey Adam made no open-market trades at EBS in the last 12 months.
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-06-13 | 2023-06-09 | EBS | Emergent BioSolutions Inc. | Havey Adam | EVP, Business Ops | A - Grant | $0.00 | +73.8K | 174.4K | +73% | $0 |
| DM | 2023-03-06 | 2023-03-02 | EBS | Emergent BioSolutions Inc. | Havey Adam | EVP, Business Ops | A - Grant | $0.00 | +18.5K | 88.2K | +26% | $0 |
| 2023-03-02 | 2023-02-28 | EBS | Emergent BioSolutions Inc. | Havey Adam | EVP, Business Ops | F - Tax | $12.38 | -998 | 33.9K | -3% | -$12.4K | |
| M | 2023-02-27 | 2023-02-23+ | EBS | Emergent BioSolutions Inc. | Havey Adam | EVP, Business Ops | F - Tax | $13.91 | -1,244 | 33.7K | -4% | -$17.3K |
| 2023-02-10 | 2023-02-08 | EBS | Emergent BioSolutions Inc. | Havey Adam | EVP, Business Ops | A - Grant | $0.00 | +95 | 36.9K | +0.3% | $0 | |
| 2023-02-10 | 2023-02-08 | EBS | Emergent BioSolutions Inc. | Havey Adam | EVP, Business Ops | F - Tax | $13.25 | -1,964 | 34.9K | -5% | -$26.0K | |
| D | 2022-03-02 | 2022-02-28 | EBS | Emergent BioSolutions Inc. | Havey Adam | EVP, Business Ops | F - Tax | $39.64 | -739 | 86.2K | -0.9% | -$29.3K |
| DM | 2022-03-02 | 2022-03-01 | EBS | Emergent BioSolutions Inc. | Havey Adam | EVP, Business Ops | A - Grant | $0.00 | +50.1K | 69.1K | +264% | $0 |
| M | 2022-02-25 | 2022-02-23+ | EBS | Emergent BioSolutions Inc. | Havey Adam | EVP, Business Ops | F - Tax | $42.39 | -1,252 | 37.6K | -3% | -$53.1K |
| 2022-02-24 | 2022-02-22 | EBS | Emergent BioSolutions Inc. | Havey Adam | EVP, Business Ops | F - Tax | $42.23 | -1,980 | 38.0K | -5% | -$83.6K | |
| 2022-02-24 | 2022-02-22 | EBS | Emergent BioSolutions Inc. | Havey Adam | EVP, Business Ops | A - Grant | $0.00 | +1,836 | 40.0K | +5% | $0 |
Purchase Sale Sale after option exercise All abbreviations